n.（细胞）内溶素，（细胞）内溶菌素

Endolysin is a type of bacterial protein that cleaves the cell wall of other bacteria, making it a promising antibacterial agent.
内溶菌酶是一种细菌蛋白，能切割其他细菌的细胞壁，是作为一种有前景的抗菌剂。
Researchers have been studying endolysins as a potential alternative to traditional antibiotics in treating drug-resistant infections.
研究人员正在研究内溶菌酶作为治疗耐药性感染的传统抗生素的潜在替代品。
The engineered endolysin displayed high specificity towards the target bacteria, minimizing damage to the host cells.
工程化的内溶菌酶对目标细菌具有高度特异性，对宿主细胞的损害最小化。
In medical applications, endolysins are being investigated for their ability to degrade biofilms, which are hard-to-treat bacterial colonies.
在医疗应用中，内溶菌酶因其分解生物膜的能力而被研究，生物膜是难以治疗的细菌群落。
A novel endolysin was discovered in the soil bacterium Streptomyces griseus, offering new possibilities in bioremediation.
在土壤细菌Streptomyces griseus中发现了一种新型内溶菌酶，为生物修复提供了新的可能性。
Scientists are developing targeted endolysins that can specifically recognize and degrade pathogenic bacteria without harming beneficial ones.
科学家们正在研发能特异性识别并分解病原菌而不伤害有益菌的靶向内溶菌酶。
Endolysins have shown promise in reducing the severity of respiratory tract infections caused by Streptococcus pneumoniae.
内溶菌酶在减轻由肺炎链球菌引起的呼吸道感染严重度上显示出前景。
Researchers combined endolysin with a delivery system to enhance its effectiveness in treating skin infections.
研究人员将内溶菌酶与递送系统结合，以提高其治疗皮肤感染的效果。
The use of endolysins in combination with other antimicrobial agents could lead to more effective treatment strategies for multi-drug resistant infections.
内溶菌酶与其他抗菌剂的联合使用可能带来更有效的多药耐药感染治疗策略。
Future studies will focus on optimizing the stability and production of endolysins to make them more practical for widespread clinical application.
未来的研究将集中在优化内溶菌酶的稳定性与生产，使其在临床应用中更加实用。